Insider Trades
IDEXX CEO Mazelsky Sells $17.7 Million Of Stock After Exercising Options
Jonathan Mazelsky still holds 83,803 IDEXX shares after selling 25,140 on Wednesday, the same day he exercised options.
IDEXX Laboratories (IDXX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Insider Trades
Jonathan Mazelsky still holds 83,803 IDEXX shares after selling 25,140 on Wednesday, the same day he exercised options.
Insider Trades
The planned sale of IDEXX stock follows a same-day option exercise, and the shares are down about 7% over 12 months as of Tuesday's close.
Earnings
Mike Erickson says CancerDx is becoming a multi-cancer panel, and IDEXX raised its 2026 revenue range to $4,741,000,000 to $4,767,000,000.
Markets
The pet-diagnostics company lifted its yearly outlook but trimmed its operating margin target, and its shares jumped in Monday trading.
Earnings
Third-quarter revenue reached $1,214 million and EPS $4.01, while the full-year operating margin outlook slipped to 32.1%–32.3%.
SEC Filings
The Vanguard unit's 3,974,472 shares are held as an investment adviser, with no aim to influence control of the veterinary diagnostics company.